Trial Profile
A single center, prospective, pilot study to evaluate the efficacy of additional treatment with Teneligliptin on left ventricular function in patients with Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2017
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 May 2017 New trial record